ML vs. SRPT
Compare and contrast key facts about MoneyLion Inc. (ML) and Sarepta Therapeutics, Inc. (SRPT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ML or SRPT.
Key characteristics
| ML | SRPT | |
|---|---|---|
| YTD Return | 30.13% | 22.20% |
| 1Y Return | 159.48% | 48.32% |
| 3Y Return (Ann) | -22.55% | 11.60% |
| Sharpe Ratio | 2.04 | 1.00 |
| Sortino Ratio | 2.66 | 2.12 |
| Omega Ratio | 1.33 | 1.26 |
| Calmar Ratio | 2.09 | 0.88 |
| Martin Ratio | 5.82 | 3.57 |
| Ulcer Index | 32.96% | 13.68% |
| Daily Std Dev | 93.28% | 48.93% |
| Max Drawdown | -97.57% | -98.17% |
| Current Drawdown | -78.02% | -34.07% |
Fundamentals
| ML | SRPT | |
|---|---|---|
| Market Cap | $905.64M | $11.62B |
| EPS | $0.27 | $1.54 |
| PE Ratio | 302.15 | 78.97 |
| Total Revenue (TTM) | $500.28M | $1.64B |
| Gross Profit (TTM) | $244.02M | $1.40B |
| EBITDA (TTM) | $38.51M | $70.22M |
Correlation
The correlation between ML and SRPT is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ML vs. SRPT - Performance Comparison
In the year-to-date period, ML achieves a 30.13% return, which is significantly higher than SRPT's 22.20% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ML vs. SRPT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoneyLion Inc. (ML) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ML vs. SRPT - Dividend Comparison
Neither ML nor SRPT has paid dividends to shareholders.
Drawdowns
ML vs. SRPT - Drawdown Comparison
The maximum ML drawdown since its inception was -97.57%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for ML and SRPT. For additional features, visit the drawdowns tool.
Volatility
ML vs. SRPT - Volatility Comparison
MoneyLion Inc. (ML) has a higher volatility of 32.44% compared to Sarepta Therapeutics, Inc. (SRPT) at 9.19%. This indicates that ML's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ML vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between MoneyLion Inc. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities